Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma

Published:2015-03-03 Issue:3 Volume:10 Page:e0118829
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hori Yasuki,Miyabe Katsuyuki,Yoshida Michihiro,Nakazawa Takahiro,Hayashi Kazuki,Naitoh Itaru,Shimizu Shuya,Kondo Hiromu,Nishi Yuji,Umemura Shuichiro,Kato Akihisa,Ohara Hirotaka,Inagaki Hiroshi,Joh Takashi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Trends in the treatment and outcome of pancreatic cancer in the United States;NN Baxter;Ann Surg Oncol,2007

2. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study;Y Shaib;The American journal of gastroenterology,2007

3. Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973–2002;J Zhang;Ann Oncol,2007

4. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans;GL Bond;Cell,2004

5. Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer. World journal of gastroenterology;M Dong;WJG,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review;Frontiers in Oncology;2022-08-19

2. Frequency of hyperglycemia and polymorphism of TNF and TP53 genes in patients with acute pancreatitis, chronic pancreatitis, pancreatic cancer;Diabetes mellitus;2021-10-15

3. Impact of physiologically shaped pancreatic stent for chronic pancreatitis;Scientific Reports;2021-04-15

4. Blood-tissue analysis of TP53 polymorphisms and survival of patients with glioma;Journal of Neurosurgical Sciences;2021-01

Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?

;OncoTargets and Therapy;2020-03